432 Participants Needed

Melanated Group Midwifery Care for Maternal Care

(MGMC Trial)

KL
Overseen ByKylea L Liese, PhD
Age: < 65
Sex: Female
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new approach to maternity care that might boost trust and engagement for Black birthing people. The study compares usual prenatal visits to a group care model called Melanated Group Midwifery Care. Led by Black midwives and care coordinators, this model includes group sessions, personalized support, and postpartum doula visits. It is designed for pregnant women who identify as Black, are less than 20 weeks pregnant, and visit the University of Chicago Medical Center for their first prenatal check-up. The trial aims to determine if this approach positively impacts the pregnancy and postpartum experience. As an unphased trial, it offers a unique opportunity to contribute to innovative maternity care research that could enhance experiences for future Black birthing individuals.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this midwifery care method is safe?

Research has shown that Melanated Group Midwifery Care (MGMC) represents a new approach to maternity care. Although past studies have not provided specific safety data, this method involves a supportive team of Black midwives, nurses, and doulas (trained birth assistants). The team-based care aims to improve pregnancy outcomes for Black birthing people.

MGMC is neither a drug nor a medical device, so traditional safety concerns like side effects do not apply. Instead, the focus is on providing consistent support and engagement throughout pregnancy and after birth. While concrete safety data is lacking, the approach seeks to offer a more personalized and culturally sensitive experience, potentially enhancing trust and satisfaction.12345

Why are researchers excited about this trial?

Researchers are excited about Melanated Group Midwifery Care (MGMC) because it offers a culturally tailored and community-focused approach to maternal care, particularly for Black women. Unlike the usual care, which often lacks continuity and racial concordance, MGMC provides consistent care by the same two co-facilitators, a Black midwife and a Black care coordinator, throughout the pregnancy and postpartum period. This method emphasizes proactive support, including appointment coordination and community-based postpartum doula services, aiming to enhance maternal and infant health outcomes by addressing the unique needs and challenges faced by Black women during and after pregnancy.

What evidence suggests that Melanated Group Midwifery Care is effective for improving patient trust and engagement among Black birthing people?

Research has shown that Melanated Group Midwifery Care (MGMC), which participants in this trial may receive, aims to improve the maternity care experience for Black birthing people. Studies have found that care from a consistent team of Black midwives and doulas can lead to better pregnancy outcomes. This approach includes group prenatal care, which builds trust and increases patient involvement. The program also offers support from a care coordinator and a postpartum doula, ensuring that participants attend and understand appointments. Early findings suggest this model of care might help reduce disparities in maternal health outcomes.12567

Who Is on the Research Team?

SL

Stacie L Geller, PhD

Principal Investigator

University of Illinois Chicago

Are You a Good Fit for This Trial?

This trial is for English-speaking pregnant women who identify as Black, are less than 20 weeks pregnant, and at least 15 years old. They must be new to prenatal care at the University of Chicago Medical Center. Black midwives, care coordinators, and community postpartum doulas from the same center can also join.

Inclusion Criteria

I am 15 years old or older.
Present to the general obstetrics group at the University of Chicago Medical Center for their new prenatal visit
All Black midwives, care coordinators, and community postpartum doulas at the University of Chicago are eligible to participate.
See 3 more

Exclusion Criteria

I am able to understand and agree to the study's requirements.
Having a condition for which they present to a higher level of obstetrics care (e.g., maternal fetal medicine) for their new prenatal visit

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Prenatal Care

Participants receive prenatal care from a Black midwife in groups with the same 8-10 other Black women throughout pregnancy.

Up to 37 weeks gestation
3 visits (in-person) at baseline, 26-28 weeks, and 35-37 weeks

Postnatal Care

Participants receive postnatal care and support from a postpartum doula and care coordinator.

12 months postpartum
Home visits by doula within first 2 weeks postpartum, ongoing support available

Follow-up

Participants are monitored for patient trust, respect, and engagement through surveys and qualitative interviews.

12 months postpartum
3 survey time points at 2, 6, and 12 months postpartum

What Are the Treatments Tested in This Trial?

Interventions

  • Melanated Group Midwifery Care
Trial Overview The study tests a Melanated Group Midwifery Care model to see if it boosts trust and engagement in Black birthing individuals during maternity care by comparing their experiences with standard practices.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: MGMC Intervention GroupExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Melanated Group Midwifery Care is already approved in United States for the following indications:

🇺🇸
Approved in United States as Melanated Group Midwifery Care for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

University of Chicago

Collaborator

Trials
1,086
Recruited
844,000+

Published Research Related to This Trial

In a study of 244,047 singleton, term deliveries in New Zealand, medical-led maternity care was associated with significantly lower odds of adverse perinatal outcomes, such as low Apgar scores and birth-related asphyxia, compared to midwife-led care.
Despite the benefits of midwife-led care, such as higher patient satisfaction, the study found an unexplained excess of adverse events in midwife-led deliveries, indicating a need for further investigation into the safety and outcomes of this model.
A Comparison of Midwife-Led and Medical-Led Models of Care and Their Relationship to Adverse Fetal and Neonatal Outcomes: A Retrospective Cohort Study in New Zealand.Wernham, E., Gurney, J., Stanley, J., et al.[2019]
Midwifery Group Practice (MGP) showed significant benefits for Moderate Risk women, with fewer assisted deliveries and labor inductions compared to other care models, indicating a potentially safer and more effective approach.
MGP also resulted in less use of epidural analgesia across all risk categories, suggesting a preference for more natural birthing methods, while maintaining similar safety outcomes in terms of post-partum hemorrhage and neonatal admissions.
An evaluation of Midwifery Group Practice. Part I: clinical effectiveness.Turnbull, D., Baghurst, P., Collins, C., et al.[2019]
Infants of mothers who received midwifery group practice (MGP) care during pregnancy showed better neurodevelopmental outcomes at 6 months, particularly in fine motor and problem-solving skills, compared to those whose mothers received standard hospital care (SC).
Even when accounting for maternal stress due to a natural disaster, the MGP model was associated with a lower risk of developmental delays in infants, highlighting the importance of continuity in midwifery care for improving infant outcomes in stressful situations.
Disaster in pregnancy: midwifery continuity positively impacts infant neurodevelopment, QF2011 study.Simcock, G., Kildea, S., Kruske, S., et al.[2023]

Citations

1.mgmc.uic.edumgmc.uic.edu/
Melanated Group Midwifery Care | University of Illinois ChicagoMelanated Group Midwifery Care (MGMC) is a research study to test if care from a team of Black midwives, nurses and doulas can improve pregnancy outcomes for ...
Melanated Group Midwifery Care: Centering the Voices of ...The purpose of this article is to describe a multicomponent maternity care innovation, Melanated Group Midwifery Care (MGMC).
Study Overview - Melanated Group Midwifery CareThe purpose of the study is to compare the usual maternity care received by most pregnant people to a new model of maternity care, called Melanated Group ...
Maternal Morbidity and Mortality (MMM)The research study team is testing a program called Melanated Group Midwifery Care, which aims to improve the care Black women receive before and after giving ...
Project Goals - Melanated Group Midwifery CareA new model of care for Black birthing people. It is a patient-centered and community-engaged project and it is composed of four evidence-based interventions.
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/36480019/
Melanated Group Midwifery Care: Centering the Voices of ...The purpose of this article is to describe a multicomponent maternity care innovation, Melanated Group Midwifery Care (MGMC).
Melanated Group Midwifery Care: Centering the Voices of ...✦Melanated Group Midwifery Care (MGMC) is a radical reconfiguration of perinatal care designed to deliver trustworthy. care that centers the voices of Black ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security